Terbutaline Sulfate
NDC 24979-132, Terbutaline Sulfate, tablet, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 24979-132
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211832
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24979-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERBUTALINE SULFATE2.5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24979-132-01 | 24979013201 | 100 TABLET in 1 BOTTLE (24979-132-01) |
| 24979-132-03 | 24979013203 | 1000 TABLET in 1 BOTTLE (24979-132-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3a4e5046-293c-4616-8679-6da65f31626bNADAC price for package 24979013201
GET /v1/drugs/nadac/24979013201
Use it
Look up 24979-132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24979-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24979-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.